The case of a man with porphyria cutanea tarda (PCT) that damaged his eyes — a rare manifestation of…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Abnormal fatty lesions in the liver, detected via ultrasound, may be critical for diagnosing some cases of porphyria cutanea…
People with acute hepatic porphyria (AHP) tend to have higher-than-normal levels of markers for kidney injury, new research suggests.
Long-term treatment with Givlaari (givosiran) lessens rates of porphyria attacks, eases pain, and improves quality of life in…
By February, eligible acute porphyria patients in England are expected to have access to Givlaari (givosiran) through the country’s National…
Experts will discuss the latest research related to porphyria, as well as current and emerging treatments and management strategies,…
Most people with porphyria who responded to a U.S.-based online survey report being generally satisfied with their treatment plan,…
The Assistance Fund (TAF) is accepting new eligible patients in the U.S. into its financial aid program for porphyria.
A baby girl was found to have congenital erythropoietic porphyria, highlighting the importance of closely examining the bone marrow for…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…